Higher BMI was associated with improved survival among patients with prostate cancer, especially those with metastatic disease.

SAN FRANCISCO -- For patients with recurrent prostate cancer, those with a certain subtype had clinically meaningful benefits ...

The global hormone sensitive advanced prostate cancer (HSPC) market is witnessing substantial growth due to rising prostate cancer cases, advancements in hormonal and combination treatments, and ...

Median progression-free survival (PFS) increased from 7.4 months with stereotactic body radiotherapy (SBRT) to 17.6 months with the addition of 177 lutetium (Lu) PNT2002 targeting prostate-specific ...

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...

Patients with prostate cancer can position themselves to receive the best care possible by being seen by a multidisciplinary ...

CAN-2409 improved disease-free survival in patients with intermediate-to-high-risk, localized prostate cancer compared to placebo in patients treated with either conventional or moderate ...

September is Prostate Cancer Awareness Month, and when many men choose to get check-ups. Though the month is nearly over, ...

After revealing his prostate cancer diagnosis, Montell Jordan says early detection saved his life, and he hopes his new tour will encourage men to get screened.

BAMF Health in Grand Rapids is offering an alternative treatment for prostate cancer that doesn't involve chemotherapy.

Research shows germline genetic testing — testing for a cancer risk gene you may have inherited — can save lives. Not just a patient’s, but their family members, as well. Hereditary Cancer Awareness ...